SCHEMBL6884785

SCHEMBL6884785

CC(=O)OC[C@H]1O[C@@H](c2nc3nc(Cl)nc(Cl)c3[nH]2)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ LMNA P02545 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ TP53 P04637 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ TSHR P16473 1/20 0.48
▸ PTPN1 P18031 1/20 0.44
▸ THRB P10828 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ CYP2D6 P10635 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ NR3C1 P04150 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11407341 0.92 TSHR (0.54) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL9232024 0.91 TSHR (0.47) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL8595649 0.91 TSHR (0.47) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL6884766 0.87 TSHR (0.44) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL6887838 0.85 TSHR (0.49) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL6882311 0.85 LMNA (0.42) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL8593099 0.82 TSHR (0.47) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL8595566 0.82 TSHR (0.47) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL15669367 0.81 MEN1 (0.48) ALDH1A1LMNAMAPTTP53TDP1
SCHEMBL8596741 0.79 TSHR (0.44) ALDH1A1LMNAMAPTTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 — — EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 — — WO disclosed
Send feedback